Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
36,681,359
-
Shares change
-
+1,182,755
-
Total reported value, excl. options
-
$4,391,736,256
-
Value change
-
+$169,794,588
-
Put/Call ratio
-
84%
-
Number of buys
-
102
-
Number of sells
-
71
-
Price
-
$119.75
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q3 2017
As of 30 Sep 2017 PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) had 227 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,681,359 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, ORBIMED ADVISORS LLC, FMR LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., Partner Fund Management, L.P., STATE STREET CORP, and CITADEL ADVISORS LLC.
This table shows 227 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.